As of July 2024, several eye-related symptoms have been linked to COVID-19, reflecting both common and more severe manifestations of the virus's impact on the eyes. The primary symptoms include:
Conjunctivitis (Pink Eye): Inflammation of the conjunctiva, presenting with red, itchy, and watery eyes, and sometimes discharge. This is one of the more frequent eye symptoms, though it occurs in a relatively low percentage of COVID-19 cases (Nebraska Medicine) (All About Vision).
Dry Eyes: A sensation of dryness or grittiness in the eyes, which can sometimes lead to blurred vision (Ada).
Eye Pain and Irritation: Discomfort or pain in the eyes, which may be due to inflammation or direct viral infection (Verywell Health).
Increased Tearing: Excessive tearing or watery eyes, often accompanying other symptoms like irritation and redness (Ada).
Photophobia: Sensitivity to light, causing discomfort in bright conditions (All About Vision).
Blurry Vision: Blurred vision can result from several underlying conditions linked to COVID-19, including dry eyes, conjunctivitis, and retinal issues (Ada).
Retinal Complications: In more severe cases, COVID-19 can lead to retinal issues like retinal vein occlusion, retinal artery occlusion, and retinal hemorrhage. These conditions can cause severe visual disturbances and even permanent vision loss if not promptly treated (Ada) (Ada).
Most of these eye-related symptoms are self-limiting and tend to resolve within a couple of weeks. However, severe symptoms, especially those involving vision changes or persistent pain, warrant immediate medical attention to rule out serious complications (Verywell Health) (Ada).
For those experiencing these symptoms, supportive treatments such as lubricating eye drops, cold compresses, and avoiding eye rubbing can help alleviate discomfort. In more severe cases, medical interventions like medications to dissolve blood clots or surgery may be necessary (Ada) (Verywell Health).
It's important to consult an eye care professional if you experience significant or persistent eye symptoms during or after a COVID-19 infection to ensure proper diagnosis and treatment.